Abiomed anuncia receita de US$ 132,5 milhões para o T1 do AF 2018, aumento de 29% em relação ao ano anterior
28. Juli 2017 09:35 ET
|
Abiomed
DANVERS, Mass., July 28, 2017 (GLOBE NEWSWIRE) -- A Abiomed, Inc. (NASDAQ:ABMD), provedora líder de tecnologias inovadoras de suporte cardíaco, comunicou hoje a receita do primeiro trimestre do ano...
Abiomed anuncia ingresos de 132,5 millones de dólares para el primer trimestre del año fiscal 2018, un 29% más que el año anterior
28. Juli 2017 09:35 ET
|
Abiomed
DANVERS, Mass., July 28, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), un proveedor líder de tecnologías innovadoras para asistencia cardíaca, ha anunciado hoy ingresos de 132,5 millones de...
Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year
27. Juli 2017 07:00 ET
|
Abiomed
DANVERS, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2018 revenue of...
Abiomed First Quarter Fiscal 2018 Earnings and Conference Call Notification
06. Juli 2017 07:00 ET
|
Abiomed
DANVERS, Mass., July 06, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced that on Thursday, July 27, 2017, the Company will release financial results for the first quarter of fiscal...
New Study with Abiomed’s Impella 2.5® Heart Pump Demonstrates Potential Survival with Pre-PCI Insertion in Heart Attacks with the Left Main Coronary Artery
30. Juni 2017 08:04 ET
|
Abiomed
DANVERS, Mass., June 30, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the recent publication of a...
Heart Recovery Patients Visit Capitol Hill to Advocate for Lifesaving Cardiovascular Technology
09. Juni 2017 08:07 ET
|
Abiomed
WASHINGTON, June 09, 2017 (GLOBE NEWSWIRE) -- Nineteen patients who benefitted from treatment with Abiomed’s Impella heart pumps traveled to Washington, D.C. on June 8, 2017, to meet with elected...
Abiomed to Present at the Jefferies Healthcare Conference
30. Mai 2017 08:00 ET
|
Abiomed
DANVERS, Mass., May 30, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...
Abiomed Introduces 3rd Generation Impella CP® Heart Pumps at SCAI 2017
09. Mai 2017 09:33 ET
|
Abiomed
DANVERS, Mass., May 09, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced the debut of the 3rd Generation...
Abiomed anuncia ingresos de $124,7 millones para el cuarto trimestre del año fiscal 2017, 33% más que el año anterior, e ingresos anuales totales de $445,3 millones, 35% más que el año anterior
08. Mai 2017 10:44 ET
|
Abiomed
DANVERS, Mass., May 08, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), un proveedor líder de tecnologías innovadoras para asistencia cardíaca, anunció ingresos de $124,7 millones para el...
Abiomed ประกาศรายได้ไตรมาสที่ 4 ปีงบประมาณ 2560 จำนวน 124.7 ล้านดอลลาร์สหรัฐ เพิ่มขึ้นร้อยละ 33 จากปีก่อนและรายได้รวมที่ 445.3 ล้านดอลลาร์สหรัฐ เพิ่มขึ้นร้อยละ 35 เมื่อเทียบกับปีที่ผ่านมา
08. Mai 2017 10:44 ET
|
Abiomed
DANVERS, Mass., May 08, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) ผู้ให้บริการชั้นนำด้านเทคโนโลยีอันก้าวหน้าในด้านการสนับสนุนหัวใจได้รายงานในวันนี้เกี่ยวกับรายได้ประจำไตรมาสที่ 4...